60 related articles for article (PubMed ID: 12068634)
21. Loss of interferon-gamma inducibility of TAP1 and LMP2 in a renal cell carcinoma cell line.
Dovhey SE; Ghosh NS; Wright KL
Cancer Res; 2000 Oct; 60(20):5789-96. PubMed ID: 11059775
[TBL] [Abstract][Full Text] [Related]
22. Clinicopathological Significance of the Proliferation Markers Ki67, RacGAP1, and Topoisomerase 2 Alpha in Breast Cancer.
Şahin S; Işık Gönül İ; Çakır A; Seçkin S; Uluoğlu Ö
Int J Surg Pathol; 2016 Oct; 24(7):607-13. PubMed ID: 27284123
[TBL] [Abstract][Full Text] [Related]
23. Association between c-myc amplification and pathological complete response to neoadjuvant chemotherapy in breast cancer.
Yasojima H; Shimomura A; Naoi Y; Kishi K; Baba Y; Shimazu K; Nakayama T; Kim SJ; Tamaki Y; Noguchi S
Eur J Cancer; 2011 Aug; 47(12):1779-88. PubMed ID: 21741827
[TBL] [Abstract][Full Text] [Related]
24. [Topoisomerase IIalpha and HER2/neu gene alterations and their correlation in pancreatic ductal adenocarcinomas].
Liang ZY; Wang WZ; Gao J; Wu SF; Zeng X; Liu TH
Zhonghua Bing Li Xue Za Zhi; 2007 Feb; 36(2):102-6. PubMed ID: 17493384
[TBL] [Abstract][Full Text] [Related]
25. [Identification of prognostic parameters for renal cell carcinoma by cDNA arrays and cell chips].
Moch H; Schraml P; Bubendorf L; Mirlacher M; Kononen J; Gasser T; Mihatsch MJ; Kallioniemi OP; Sauter G
Verh Dtsch Ges Pathol; 1999; 83():225-32. PubMed ID: 10714215
[TBL] [Abstract][Full Text] [Related]
26. [Molecular genetic mechanism of the kidney cancer].
Nakaigawa N; Yao M; Kishida T; Kubota Y
Nihon Rinsho; 2001 Jan; 59(1):104-9. PubMed ID: 11197838
[TBL] [Abstract][Full Text] [Related]
27. Influence of protein tyrosine phosphorylation on the expression of the c-myc oncogene in cancer of the large bowel.
Heruth DP; Wetmore LA; Leyva A; Rothberg PG
J Cell Biochem; 1995 May; 58(1):83-94. PubMed ID: 7642726
[TBL] [Abstract][Full Text] [Related]
28. MEK1 and the extracellular signal-regulated kinases are required for the stimulation of IL-2 gene transcription in T cells.
Whitehurst CE; Geppert TD
J Immunol; 1996 Feb; 156(3):1020-9. PubMed ID: 8557975
[TBL] [Abstract][Full Text] [Related]
29. Activation of Src in human breast tumor cell lines: elevated levels of phosphotyrosine phosphatase activity that preferentially recognizes the Src carboxy terminal negative regulatory tyrosine 530.
Egan C; Pang A; Durda D; Cheng HC; Wang JH; Fujita DJ
Oncogene; 1999 Feb; 18(5):1227-37. PubMed ID: 10022129
[TBL] [Abstract][Full Text] [Related]
30. c-Yes tyrosine kinase activity in human colon carcinoma.
Park J; Meisler AI; Cartwright CA
Oncogene; 1993 Oct; 8(10):2627-35. PubMed ID: 7690925
[TBL] [Abstract][Full Text] [Related]
31. Gene expression profiling of favorable histology Wilms tumors and its correlation with clinical features.
Takahashi M; Yang XJ; Lavery TT; Furge KA; Williams BO; Tretiakova M; Montag A; Vogelzang NJ; Re GG; Garvin AJ; Söderhäll S; Kagawa S; Hazel-Martin D; Nordenskjold A; Teh BT
Cancer Res; 2002 Nov; 62(22):6598-605. PubMed ID: 12438255
[TBL] [Abstract][Full Text] [Related]
32. Conventional and array-based comparative genomic hybridization analyses of novel cell lines harboring HPV18 from glassy cell carcinoma of the uterine cervix.
Hirai Y; Kawamata Y; Takeshima N; Furuta R; Kitagawa T; Kawaguchi T; Hasumi K; Sugai S; Noda T
Int J Oncol; 2004 Apr; 24(4):977-86. PubMed ID: 15010838
[TBL] [Abstract][Full Text] [Related]
33. Analysis of c-myc oncogene in human esophageal carcinoma: immunohistochemistry, in situ hybridization and northern and Southern blot studies.
Miyazaki S; Sasno H; Shiga K; Sawai T; Nishihira T; Okamoto H; Mori S
Anticancer Res; 1992; 12(5):1747-55. PubMed ID: 1444241
[TBL] [Abstract][Full Text] [Related]
34. Overexpression of the met/HGF receptor in renal cell carcinomas.
Natali PG; Prat M; Nicotra MR; Bigotti A; Olivero M; Comoglio PM; Di Renzo MF
Int J Cancer; 1996 Jun; 69(3):212-7. PubMed ID: 8682590
[TBL] [Abstract][Full Text] [Related]
35. Topoisomerase IIalpha gene amplification in gastric carcinomas: correlation with the HER2 gene. An immunohistochemical, immunoblotting, and multicolor fluorescence in situ hybridization study.
Kanta SY; Yamane T; Dobashi Y; Mitsui F; Kono K; Ooi A
Hum Pathol; 2006 Oct; 37(10):1333-43. PubMed ID: 16949920
[TBL] [Abstract][Full Text] [Related]
36. Dual-specificity phosphatase 1 and serum/glucocorticoid-regulated kinase are downregulated in prostate cancer.
Rauhala HE; Porkka KP; Tolonen TT; Martikainen PM; Tammela TL; Visakorpi T
Int J Cancer; 2005 Dec; 117(5):738-45. PubMed ID: 15981206
[TBL] [Abstract][Full Text] [Related]
37. Interleukin 6 inhibits proliferation and, in cooperation with an epidermal growth factor receptor autocrine loop, increases migration of T47D breast cancer cells.
Badache A; Hynes NE
Cancer Res; 2001 Jan; 61(1):383-91. PubMed ID: 11196191
[TBL] [Abstract][Full Text] [Related]
38. Expression of Y box-binding protein-1 correlates with DNA topoisomerase IIalpha and proliferating cell nuclear antigen expression in lung cancer.
Gu C; Oyama T; Osaki T; Kohno K; Yasumoto K
Anticancer Res; 2001; 21(4A):2357-62. PubMed ID: 11724293
[TBL] [Abstract][Full Text] [Related]
39. Tumor topoisomerase II alpha status and response to anthracycline-based neoadjuvant chemotherapy in breast cancer.
Nikolényi A; Sükösd F; Kaizer L; Csörgo E; Vörös A; Uhercsák G; Ormándi K; Lázár G; Thurzó L; Brodowicz T; Kahán Z
Oncology; 2011; 80(3-4):269-77. PubMed ID: 21734419
[TBL] [Abstract][Full Text] [Related]
40. Protein-tyrosine phosphatases: the other side of the coin.
Hunter T
Cell; 1989 Sep; 58(6):1013-6. PubMed ID: 2550140
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]